Hence, expression of the EGF‐inducible lncRNAs we uncovered was examined in large cohorts of breast cancer patients, with the vision of identifying potential drivers and biomarkers of the basal‐like and the HER2‐enriched subtypes. The gene discussed is EGF; the disease is breast carcinoma.